Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7640-7647

  Pewe, Lecia ^a   Xue, Shurong ^b   Perlman, Stanley ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; COMBINED IMMUNODEFICIENCY; CORONAVIRUS; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; GENE MUTATION; LYMPHOCYTIC INFILTRATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; VIRUS INFECTION; VIRUS VIRULENCE;

EID: 0030768760     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7640-7647.1997     Document Type: Article

References (43)

1. Adami, C., J. Pooley, J. Glomb, E. Stecker, F. Eazal, J. O. Fleming, and S. C. Baker. 1995. Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecics nature of the persisting MHV RNA. Virology 209: 337-346.
2. Bergmann, C. C., Q. Yao, M. Lin, and S. A. Stohlman. 1996. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted CTL response. J. Gen. Virol. 77:315-325.
3. Bertoletti, A., A. Costanzo, F. V. Chisari, M. Levrero, M. Artini, A. Seite, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933-943.
4. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410.
5. Bureau, J.-F., X. Montagutelli, F. Bihl, S. Lefebvre, J.-L. Guenet, and M. Brahic. 1993. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5:87-91.
6. Castro, R. F., G. D. Evans, A. Jaszewski, and S. Perlman. 1994. Coronavirus- induced demyelination occurs in the presence of virus-specific cytotoxic T cells. Virology 200:733-743.
7. Castro, R. F., and S. Perlman. 1995. CD8+ T cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenic ity. J. Virol. 69:8127-8131.
8. Dalziel, R. G., P. W. Lampert, P. J. Talbot, and M. J. Buchmtier. 1986. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:463-471.
9. Falk, K., and O. Rötzschke. 1993. Consensus motifs and peptide ligands of MHC class I molecules. Semin. Immunol. 5:81-94.
10. Franco, A., C. Ferrari, A. Sette, and F. V. Chisari. 1995. Viral mutations, TCR antagonism and escape from the immune response. Curr. Opin. Immunol. 7:524-531.
11. Gallagher, T., S. E. Parker, and M. J. Buchmeier. 1990. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J. Virol. 64:731-741.
12. Houtman, J. J., and J. O. Fleming. 1996. Dissociation of demyelination and viral clearance in congenially immunodeficient mice infected with murine coronavirus JHM. J. Neurovirol. 2:101-110.
13. Houtman, J. J., and J. O. Fleming. 1996. Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol. 2:361-376.
14. Jacobsen, G., and S. Perlman. 1990. Localization of virus and antibody response in mice infected persistently with MHV-JHM. Adv. Exp. Med. Biol. 276:573-578.
15. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Glangrande, R. E. Phillips, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants. Nature 369:403-407.
16. Kyuwa, S., and S. A. Stohlman. 1990. Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Semin. Virol. 1:273-280.
17. LaMonica, N., L. R. Banner, V. L. Morris, and M. M. C. Lai. 1991. Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology 182:883-888.
18. Lane, T. E., and M. J. Buchmeier. 1997. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol. 5:9-14.
19. Lewicki, H., M. Von Herrath, C. Evans, J. L. Whitton, and M. Oldstone. 1995. CTL escape viral variants. II. Biologic activity in vivo. Virology 211: 443-450.
20. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, A. L.B. Morfeldt-Manson, and S. Wain-Hobson. 1989. Temporal fluctuations HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910.
21. Moskophidis, D., and R. M. Zinkernagel. 1995. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69: 2187-2193.
22. Nonoyama, S., F. O. Smith, I. D. Bernstein, and H. D. Ochs. 1993. Strain-dependent leakiness of mice with severe combined immune deficiency. J. Immunol. 150:3817-3824.
23. Nowak, M. A., and C. R. M. Bangham. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74-79.
24. Parker, S. E., T. M. Gallagher, and M. J. Buchmeier. 1989. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173: 664-673.
25. Pearce, B. D., M. V. Hobbs, T. S. McGraw, and M. J. Buchmeier. 1994 Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 68:5483-5495.
26. Perlman, S., G. Jacobsen, and A. Afifi. 1989. Spread of a neurotropic murine coronavirus into the CNS via the trigeminal and olfactory nerves. Virology 170:556-560.
27. Perlman, S., R. Schelper, E. Bolger, and D. Ries. 1987. Late onset, symptomatic, demyelinating enccphalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb. Pathog. 2:185-194.
28. Pewe, L., G. Wu, E. M. Barnett, R. Castro, and S. Perlman. 1996. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5:253-262.
29. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453-459.
30. Pircher, H., D. Moskophidis, U. Rohrer, K. Burki, H. Hengartner. and R. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633.
31. Rehermann, B., C. Pasquinelli, S. Mosier, and F. Chisari. 1995. Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J. Clin. Invest. 96:1527-1534.
32. Rowe, C. L., S. C. Baker, M. J. Nathan, and J. O. Fleming. 1997. Evolution of mouse hepatitis virus: detection and characterization of S1 deletion vanants during persistent infection. J. Virol. 71:2959-2967.
33. Stevenson, P. G., S. Hawke, D. J. Sloan, and C. R. M. Bangham. 1997. The immunogenicity of intraccrebral virus infection depends on anatomical site. J. Virol. 71:145-151.
34. Stohlman, S. A., S. Kyuwa, M. Cohen, C. Bergmann, J. M. Polo, J. Yeh, R. Anthony, and J. G. Keck. 1992. Mouse hepatitis virus nucleocapsid protein- specific cytotoxic T lymphocytes are Ld-restricted and specific for the carboxy terminus. Virology 189:217-224.
35. Stohlman, S. A., S. Kyuwa, J. M. Polo, D. Brady, M. M. C. Lai, and C. C. Bergmann. 1993. Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J. Virol. 67:7050-7059.
36. Sun, N., D. Grzybicki, R. Castro, S. Murphy, and S. Perlman. 1995. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213:482-493.
37. Vollmer, T. L. 1996. Multiple sclerosis: new approaches to immunotherapy. Neuroscientist 2:127-136.
38. Wang, F., J. O. Fleming, and M. M. C. Lai. 1992. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology 186:742-749.
39. Weidt, G., W. Deppert, O. Utermohlen, J. Heukeshoven, and F. Lehmann-Grube. 1995. Emergence of virus escape mutants after immunization with epitope vaccine. J. Virol. 69:7147-7151.
40. Williamson, J. S., K. C. Sykes, and S. A. Stohlman. 1991. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 32:199-207.
41. Wolinsky, S. M., B. Korber, A. U. Neumann, M. Daniels, K. Kunsttnan, A. Whetsell, M. Furtado, V. Cao, D. Ho, J. Safrit, and R. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during ihe natural course of infection. Science 272:537-542.
42. Young, A., W. Zhang, J. Sacchettini, and S. Nathenson. 1994. The three-dimensional structure of H-2D at 2.4 A resolution: implications for antigen-determinant selection. Cell 76:39-50.
43. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271:173-178.